1. Home
  2. SR vs IMVT Comparison

SR vs IMVT Comparison

Compare SR & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spire Inc.

SR

Spire Inc.

HOLD

Current Price

$90.02

Market Cap

4.9B

Sector

Utilities

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$24.65

Market Cap

5.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SR
IMVT
Founded
1857
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SR
IMVT
Price
$90.02
$24.65
Analyst Decision
Buy
Buy
Analyst Count
9
9
Target Price
$88.11
$30.78
AVG Volume (30 Days)
280.9K
1.0M
Earning Date
04-29-2026
02-06-2026
Dividend Yield
3.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.19
N/A
Revenue Next Year
$7.84
N/A
P/E Ratio
$19.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$71.24
$12.72
52 Week High
$94.27
$29.25

Technical Indicators

Market Signals
Indicator
SR
IMVT
Relative Strength Index (RSI) 49.32 45.61
Support Level $88.84 $21.74
Resistance Level $92.20 $27.71
Average True Range (ATR) 1.87 1.12
MACD -0.41 -0.15
Stochastic Oscillator 28.01 48.68

Price Performance

Historical Comparison
SR
IMVT

About SR Spire Inc.

Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: